The Challenge Currently, there are no broad-spectrum antivirals or immunotherapies available for the fight against emerging pathogens, and very few treatments approved for use against COVID-19. To effectively address COVID-19, the world will require multiple prevention and treatment options. The CTA is working to coordinate R&D efforts to help remove barriers to drug development and […]